BIBLIOGRAPHY
ACC AHA/ESC Guidelines for the management of patients with supraventricular arrhythmias — Executive summary. J. Am. Coll. Cardiol., 42:1494–1529, 2003
Alboni, P., Bott, G. L., Bald, N. et al. Outpatient treatment of recent-onset atrial fibrillation with the ‘‘Pill-in-the-Pocket’’ approach. N. Engl. J. Med., 351:2384–2391, 2004.
Becker, R. C. et al. Novel constructs for thrombin inhibition. AM. HEAR. J., 149:S61–S72, 2005.
Bourassa, M. G. et al. Angiotensin II inhibition and prevention of atrial fibrillation and stroke. J. Am. Coll. Cardiol., 45:720–721, 2005.
Eckardt, L., Probst, V., Smits, J. P. P. et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation, 111:257–263, 2005.
Ferguson, J. D., and DiMarco, J. P. Contemporary management of paroxysmal supraventricular tachycardia. Circulation, 107:1096, 2003.
Gaita, F., Riccardi, R., Caponi, D. et al. Linear cryo ablation of the left atrium versus pulmonary vein cryo isolation in patients with per¬manent atrial fibrillation and valvular heart disease: Correlation of electro-anatomic mapping and long-term clinical results. Circulation, 111:136–142, 2005.
Halperin, J. L. et al. Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation. J. Am. Coll. Cardiol., 45:1–9, 2005.